GSK and Pfizer join forces to create a new company focused on HIV. I really like the idea here – I think highly-focused companies can be much more nimble and effective.
Dendreon finally gets some good clinical news about experimental prostate cancer treatment Provenge.
B-I launches new unbranded website for TIA (mini-stroke) sufferers.
If there was any doubt as to who was taking over whom (Roche/Genetech), let’s put that to rest.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff
Leave a Reply